Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.
about
IFITM3 inhibits influenza A virus infection by preventing cytosolic entryInvolvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 EntrySERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by NefHIV-1 Nef promotes infection by excluding SERINC5 from virion incorporationLow pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoatingCharacterizing the anti-HIV activity of papuamide AThe β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion MechanismsImaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusionTime-Resolved Imaging of Single HIV-1 Uncoating In Vitro and in Living CellsP2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor InteractionsSynchronized retrovirus fusion in cells expressing alternative receptor isoforms releases the viral core into distinct sub-cellular compartmentsDopamine receptor activation increases HIV entry into primary human macrophagessiRNA screening of a targeted library of DNA repair factors in HIV infection reveals a role for base excision repair in HIV integrationHIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenonSequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoproteinNef does not contribute to replication differences between R5 pre-AIDS and AIDS HIV-1 clones from patient ACH142Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitopeTime-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infectionHuman immunodeficiency virus fusion to dendritic cells declines as cells mature.Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells.Expansion of activated memory CD4+ T cells affects infectivity of CCR5-tropic HIV-1 in humanized NOD/SCID/JAK3null mice.Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression.Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion.The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry InhibitorsThe tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.Gene therapy progress and prospects: viral trafficking during infection.Intracellular trafficking of retroviral vectors: obstacles and advances.Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.Rev-dependent indicator T cell lineIntracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear importComparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cellsNef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.
P2860
Q21090493-C95E777C-B2BE-4AEF-811F-9097F3FA92ACQ22242226-DB0E5B1D-93E3-4B68-972F-9FB33BE165ADQ24338889-07F3225E-29E2-471F-A984-EC6AA888AF91Q24338895-B0B51805-B518-4A83-951D-755ED118998AQ24562016-ED7C3F82-AB38-4E80-8F63-C990AC9E5417Q24645399-14A26A8A-2B98-41E9-87A2-BF6A49BCCEBDQ26747003-FBA93A32-3F64-498C-8DC1-B80124A9D92EQ27312399-EDAD6A4F-A00D-4309-9D68-3D7394471FE2Q27313409-9A8C0588-8AB7-4103-BD0A-DA8F9BF77527Q27321418-820531AC-0F13-48A5-9111-CDBB2069C567Q27345572-C89DFC9C-40AB-413C-92A1-E1007A5BEAE8Q28543414-A13A04A5-BC0A-420D-BB79-57DDCD6F0434Q28741694-03BA82A5-9DB2-463D-8E92-99EFB05EDFA7Q30009553-0822DA52-E67A-45D2-9304-6BA96FCEE88BQ30433973-FEA973E2-74C6-4EF5-A38F-D6429029DC89Q30441489-E3C37F9D-0A27-413B-9909-44C881735F6AQ30507959-00D0BD83-DA20-484B-ACC3-39C1EEEB314DQ33504556-36026041-DB55-4FA0-B3F8-99D3A5193E57Q33567639-6998CDE4-172C-4DA0-BDEE-364686B15CC1Q33880794-07E0A6C0-068F-4B09-BFBD-8426FD163974Q33927183-472A8F16-A0CA-43C8-950F-94FFB0E6102DQ34078521-D8B5841A-C3D2-4F63-9DDD-BB4E03C7E446Q34148120-DB6C2792-FBC0-48F7-8E2D-CAFCBDF4514BQ34315133-F08B1630-8245-442A-AB98-76BA43F7909DQ34353507-D2FB83C3-D817-4858-979F-77BD124D5BA5Q34412803-657A1117-BC2A-43E3-B383-29617B62EDF9Q34542521-EDF46D01-91DE-4DD5-A648-4AE1881572D6Q34806205-A3947E5A-8CE3-407C-9AD0-2A51A51A6479Q35173023-21124048-A90D-45BB-8DF3-DCB145A67EC4Q35542648-C34D30C3-8A0D-4051-B4A2-6EFFBEE77618Q35600803-3F7480CA-791E-4053-A7EE-2F285C734910Q35741691-E64A6D49-4F6E-4993-8F90-03FF49592BBBQ36252999-DFF86BB4-A888-417D-B6D3-D7B54B51AA87Q36314656-C6E07FC3-8A23-4965-8866-830B3E3B184CQ36602029-E913A0FD-CE3A-440C-A0BE-A2570C305B69Q36629200-8EBAAED4-EE63-4583-8C64-86CB3883C8FEQ36683376-B042827E-BDED-491E-A106-C218814FB5E8Q36759728-76D21156-EB4E-4210-99C5-94254FA314B2Q36919844-CE310E4E-3D28-4585-A804-B49D0B792CF9Q36949578-BA34D007-83F3-46C1-ACB3-693D8136DC95
P2860
Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Nef does not affect the effici ...... pe 1 fusion with target cells.
@en
type
label
Nef does not affect the effici ...... pe 1 fusion with target cells.
@en
prefLabel
Nef does not affect the effici ...... pe 1 fusion with target cells.
@en
P2093
P2860
P1433
P1476
Nef does not affect the effici ...... pe 1 fusion with target cells.
@en
P2093
Christopher A Lundquist
Christopher Aiken
Janet E Lineberger
Michael D Miller
Minoru Tobiume
P2860
P304
10645-10650
P356
10.1128/JVI.77.19.10645-10650.2003
P407
P577
2003-10-01T00:00:00Z